Origin Energy (ASX: ORG) delivers A$911m APLNG dividend but flags FY27 decline as data breach exposes 900,000 customers
Read More Pharma Industry News Susvimo EU recommendation gives Roche a new weapon in the battle for longer-lasting eye treatments Roche moves Susvimo toward EU approval as its refillable eye implant targets injection burden and strengthens a CHF 2.1 billion retinal franchise. bySoujanya RaviJuly 29, 2026